Intangible Assets, Development Spending, and Amortisation

Learning objectives

By the end of this chapter, you should be able to:

• Distinguish intangible assets from tangible non-current assets by focusing on identifiability, non-physical form, and expected future benefits.
• Decide when project spending is recognised as an expense and when it is recognised as an intangible asset (with clear cut-off points).
• Calculate amortisation for finite-life intangible assets, including time-apportionment from the date the asset is available for use.
• Explain and apply impairment principles, including recoverable amount, and when testing is required for assets with finite and indefinite lives.
• Record the acquisition, amortisation (where applicable), impairment, and disposal of intangible assets using correct double-entry.
• Identify judgement areas and typical errors in development spending and subsequent measurement, and explain the impact on profit and net assets.

Overview & key concepts

Modern businesses often create value through software, licences, protected technology, platforms, and similar resources rather than physical assets. The key accounting challenge is deciding whether spending creates a specifically identifiable resource the business can protect and use (an asset) or whether it is simply a cost of operating and growing the business (an expense).

This chapter focuses on:

• recognising intangible assets using an exam-ready memory aid and a formal recognition test,
• separating exploration (research) spending (expense) from build (development) spending (possible asset),
• subsequent measurement (cost model and the limited revaluation alternative),
• amortisation for finite-life intangible assets and annual reviews,
• impairment testing (including recoverable amount, CGUs, and the key annual-testing case),
• disposal accounting.

Intangible assets

Intangible assets (what you are looking for in exam questions)

An intangible asset is a non-physical resource (not cash or a receivable) that the business can point to specifically—so it is more than general reputation—and that is expected to help generate benefits in future periods.

A useful memory aid is the “three gates”:

1. What exactly is it? (Identifiable)
2. You can clearly describe the resource. It is either something that could be dealt with separately (for example, licensed or transferred) or it exists because the entity has legally protected or contract-backed entitlement.
3. Can the entity keep the benefits? (Control)
4. The entity can access the benefits and prevent others from using them, typically through contractual terms, legal protection, or effective safeguarding of know-how.
5. Will it pay back, and can the spending be tracked?
6. There is persuasive evidence it will contribute benefits (revenue, cost savings, or other measurable advantages) and the related costs can be captured reliably in the records.

If these gates are not met, spending is recognised in profit or loss when incurred.

Intangible assets are normally presented within non-current assets. Over time, the carrying amount is reduced by amortisation (for finite-life assets) and by impairment losses where recoverability falls.

Internally generated items (brands, customer lists, similar)

Many internally generated items are not recognised as intangible assets in financial statements, even if they are valuable. Common examples include internally generated brands, mastheads, publishing titles, and customer lists. The main reason is practical: the expenditure cannot be separated reliably from the wider costs of building and maintaining the business as a whole. In exam questions, treat these costs as expenses unless the scenario clearly involves a purchased asset with a measurable cost.

Research and development spending

Projects that might create intangible assets usually move through stages:

• Exploration (research) stage:activities aimed at discovering options or proving concepts. Outcomes are uncertain, so costs are expensed as incurred.
• Build (development) stage:work directed towards creating a usable/saleable output, supported by evidence that completion and benefits are realistically achievable. Some costs from this point may be recognised as an intangible asset.

A key point: the cut-off matters. Costs incurred before the project reaches the build stage with evidence remain expenses and are not later reclassified as assets.

Capitalisation vs expense

Capitalising means recognising an intangible asset and then charging amortisation (and impairment where needed) in future periods. Expensing recognises the cost immediately.

The accounting equation effect:

• Expense: profit decreases → retained earnings decreases → equity decreases.
• Capitalise: assets increase initially; profit is reduced later through amortisation and any impairment.

Journal entry patterns:

• Expense as incurred:
• Dr Expense
• Cr Cash / Payables
• Capitalise as an intangible asset (not PPE):
• Dr Intangible asset (at cost)
• Cr Cash / Payables

Subsequent measurement

Intangible assets are usually accounted for using the cost model: cost less accumulated amortisation (if applicable) and accumulated impairment losses.

A revaluation approach is permitted only when there is an active market with observable prices. Where revaluation is used, it must be kept up to date so the carrying amount remains close to current value. This is uncommon for most intangibles (especially bespoke software and unique technology), so exam answers typically default to the cost model unless the question explicitly provides evidence of an active market.

Amortisation

Finite life

A finite-life intangible asset is amortised over its useful life. Amortisation starts when the asset is available for use (not when spending begins, and not necessarily when revenue starts).

Straight-line is commonly used unless another method better reflects consumption.

Amortisation per year = (Cost − Residual value) / Useful life

Amortisation for the period = Annual amortisation × (time available for use during the period / 12 months)

Indefinite life

An intangible asset with an indefinite useful life is not amortised. Instead, it is tested for impairment at least annually and also whenever indicators of impairment arise.

Annual reviews

Useful life, residual value, and amortisation method are reviewed at least annually. Residual value is normally nil unless there is evidence of an observable market at the end of the life or a third-party commitment to purchase the asset.

Impairment

Impairment ensures that an asset’s carrying amount is not higher than the amount expected to be recovered through use or sale.

Recoverable amount (intuition + exam meaning)

Recoverable amount is the best supportable estimate of what can be recovered from an asset (or CGU). Use the higher of:

• what it is worth in use (based on discounted future cash flows from continuing to use it), and
• what it could be sold for after selling costs (a market-based amount, net of disposal costs).

If carrying amount exceeds recoverable amount, the difference is an impairment loss recognised in profit or loss.

When is testing required?

• Finite-life intangible assets: test for impairment when there are indicators that the asset may be impaired.
• Indefinite-life intangible assets: test at least annually, and also when indicators arise.
• Intangible assets not yet available for use: annual impairment testing is required, and also whenever indicators arise.

Cash-generating units (CGUs)

Many intangibles (especially software platforms and technology assets) do not generate largely independent cash inflows on their own. In that case, impairment assessment is performed at the level of the cash-generating unit: the smallest identifiable group of assets that generates cash inflows largely independent of other assets.

If an impairment loss is identified at CGU level, the write-down is allocated within the CGU (goodwill first, then other assets broadly in proportion to their carrying amounts), subject to not reducing any individual asset below the highest of: fair value less costs of disposal (if determinable), value in use (if determinable), and zero.

Impairment entry (general form):

• Dr Impairment loss (profit or loss)
• Cr Intangible asset (or accumulated impairment)

Exam framework

Recognition (formal test)

An intangible asset is recognised only when the entity can show it has a clearly specified resource, can protect and access the benefits, has credible evidence the resource will produce payback, and can track the related costs reliably.

For internally generated projects, this explains why exploration (research) costs are expensed and only later build (development) costs may be recognised as an asset, from the point the conditions can be evidenced.

Initial measurement

Initially measured at cost, including purchase price and directly attributable costs to bring the asset to the condition necessary for it to operate as intended.

Costs typically excluded from cost:

• general administrative overheads not directly attributable,
• advertising and promotions,
• staff training,
• routine maintenance after the asset is capable of operating as intended (expense).
• Enhancements that add new functionality or capacity may qualify for capitalisation, but only when they meet the relevant recognition conditions and are directly attributable.

Development spend: the decision rule

Treat build-stage (development) spending as an intangible asset only once the project has crossed the line from experimenting to executing a deliverable plan.

That line is crossed when the entity can show both:

1. a viable route to completion and use/sale, and
2. disciplined project control over costs and outcomes.

In exam questions, look for evidence in three bundles:

• Outcome evidence:a defined specification, working design, successful testing milestones, and a credible path to a usable/saleable output.
• Business-case evidence:budgets/forecasts, identified customers or internal savings, and management actions consistent with completing and exploiting the output.
• Cost-control evidence:project coding/timesheets, supplier invoices linked to the project, and costs that are clearly attributable (not broad overhead allocations).

Cut-off point: expense everything before this evidence exists; capitalise only the qualifying build costs incurred from the crossing point onward.

Worked example

Narrative scenario

Tech Innovations Ltd is developing a new software application for commercial licensing. The project includes the following expenditure:

• Initial market research and feasibility studies: £10,000
• Prototype development and testing: £15,000
• Coding and system integration after the project enters the build stage and the business has evidence of deliverability, expected payoff, funding/resources, and reliable cost tracking: £40,000
• Legal fees to register a patent/registered right associated with the software: £5,000
• Marketing and promotional activities: £8,000
• Staff training on the new system: £3,000

The software is available for use on 1 July. The estimated useful life is 5 years with no residual value. The year-end is 31 December.

Required

1. Determine which costs are capitalised and which are expensed.
2. Calculate the amortisation charge for the year.
3. Prepare journal entries for the year.
4. Determine the carrying amount at year-end.
5. Explain the impact on the financial statements.

Solution

1) Capitalisation and expense decision

• Market research and feasibility studies (£10,000): expense (exploration stage).
• Prototype development and testing (£15,000): expense (exploration stage).
• Build-stage coding and system integration (£40,000): capitalise from the point the project has crossed the line into a deliverable build with controlled, reliably measurable costs.
• Legal fees (£5,000): capitalise if directly attributable to obtaining the legal protection that supports control of the asset.
• Marketing and promotional activities (£8,000): expense.
• Staff training (£3,000): expense.

Total expensed immediately = £10,000 + £15,000 + £8,000 + £3,000 = £36,000
Total capitalised = £40,000 + £5,000 = £45,000

2) Amortisation charge for the year

Cost capitalised: £45,000
Useful life: 5 years
Residual value: nil

Annual amortisation = £45,000 / 5 = £9,000

Available for use from 1 July to 31 December = 6 months

Amortisation for the year = £9,000 × 6/12 = £4,500

3) Journal entries for the year

(Where items are paid later, “Payables” may be used instead of “Cash”.)

(a) Exploration-stage costs (expense)

Dr Research and feasibility expense 25,000
Cr Cash / Payables 25,000

(b) Capitalised build-stage development costs and directly attributable legal costs
(Recorded within intangible assets at cost)

Dr Intangible asset (software development) 45,000
Cr Cash / Payables 45,000

(c) Marketing and training (expense)

Dr Marketing expense 8,000
Dr Training expense 3,000
Cr Cash / Payables 11,000

(d) Amortisation from date available for use (finite life)

Dr Amortisation expense 4,500
Cr Accumulated amortisation – intangible asset 4,500

4) Carrying amount at year-end (31 December)

Cost capitalised 45,000
Less accumulated amortisation (4,500)

Carrying amount = £40,500

5) Impact on the financial statements

Statement of profit or loss:

• Research and feasibility expense: £25,000
• Marketing expense: £8,000
• Training expense: £3,000
• Amortisation expense: £4,500

Total charges affecting profit for the year = £40,500.

Statement of financial position:

• Intangible asset recognised at carrying amount: £40,500
• Equity reduced through the effect of the year’s expenses and amortisation on retained earnings (before tax effects).
• Cash and/or payables reflect settlement terms (cash purchase vs credit).

Interpretation:
Capitalisation reflects that part of the project has produced a controlled resource expected to generate benefits beyond the current period. Amortisation then allocates the cost over the periods the asset is available for use and contributing benefits.

Common pitfalls and misunderstandings

• Treating all intangibles as amortised: indefinite-life intangibles are not amortised and require at least annual impairment testing.
• Missing the key mandatory annual impairment-testing case: intangible assets not yet available for use require annual impairment testing, even if they are not indefinite-life.
• Treating “authorisation” as the switch point: capitalisation starts only when evidence supports recognition and costs are tracked reliably.
• Capitalising exploration-stage work: early feasibility and prototype work is typically expensed.
• Capitalising marketing or training: these costs do not create a controlled identifiable asset.
• Starting amortisation at the wrong date: the asset must be available for use before amortisation begins.
• Ignoring annual reviews: useful life, residual value, and amortisation method should be reassessed at least annually.
• Overlooking CGUs: when cash inflows are not independent, test impairment at the CGU level rather than the individual asset level.
• Confusing cost and carrying amount: carrying amount equals cost less accumulated amortisation and impairment losses.
• Attempting a revaluation without an active market or without keeping values current: revaluation is only realistic in rare cases and must be kept up to date.

Summary

Intangible assets are recognised only when the entity can point to a specific non-physical resource, can protect and access the benefits, has credible evidence of payback, and can track the related costs reliably. Internally generated brands and similar items are typically not recognised because expenditure cannot be separated reliably from general business development.

Exploration (research) spending is expensed. Build (development) spending is capitalised only from the point the project crosses into a deliverable plan supported by evidence and reliable cost tracking, with a clear cut-off.

Finite-life intangible assets are amortised from when they are available for use, and key estimates are reviewed at least annually. Indefinite-life intangible assets are not amortised and require at least annual impairment testing. Impairment is based on recoverable amount and is often assessed at CGU level for technology assets.

FAQ

What distinguishes exploration (research) costs from build (development) costs?

Exploration (research) costs arise when the outcome is uncertain, so they are expensed as incurred. Build (development) costs may be recognised as an intangible asset only from the point the project is managed as a deliverable build with evidence of completion, expected benefits, and reliably measurable project costs.

How is amortisation calculated for a finite-life intangible?

The usual approach is straight-line.

Annual amortisation = (Cost − Residual value) / Useful life

Time-apportion if the asset becomes available for use part-way through the year.

Are all intangible assets amortised?

No. Finite-life intangible assets are amortised. Indefinite-life intangible assets are not amortised; they are tested for impairment at least annually and also whenever indicators arise.

What is recoverable amount?

Recoverable amount is the best supportable estimate of what can be recovered from an asset (or CGU), using the higher of discounted cash flows from continued use and a market-based selling amount net of selling costs.

Why is impairment sometimes assessed at CGU level?

Some intangibles do not generate cash inflows largely independent from other assets. In that case, the impairment test is performed at the cash-generating unit level: the smallest group of assets that generates largely independent cash inflows.

If impairment is found at CGU level, how is it allocated?

The write-down is allocated within the CGU (goodwill first, then other assets broadly in proportion to carrying amounts), subject to not reducing an individual asset below the highest of fair value less costs of disposal (if determinable), value in use (if determinable), and zero.

Why are marketing and training costs expensed?

Marketing promotes the product and training improves staff capability. Neither creates a controlled identifiable resource that can be measured as a separate asset, so the costs are recognised in profit or loss when incurred.

What is the revaluation model and why is it uncommon?

A revaluation approach is permitted only when there is an active market with observable prices, and it must be kept up to date. Most intangibles (especially bespoke software and unique technology) do not have an active market, so the cost model is typically used.

Summary (Recap)

This chapter explains how to recognise and measure intangible assets, with a focus on development spending, amortisation, and impairment. It uses a “three gates” memory aid and a formal recognition test. Exploration (research) costs are expensed, while build (development) costs are capitalised only from the point the project crosses into a deliverable plan supported by evidence and reliable cost tracking. Finite-life intangibles are amortised from when they are available for use and reviewed at least annually. Indefinite-life intangibles are not amortised and require at least annual impairment testing, and intangible assets not yet available for use also require annual impairment testing. Recoverable amount is assessed using discounted value-in-use and net selling value, and technology assets are often tested at CGU level with impairment allocated within the CGU using clear floors.

Glossary

Intangible asset
A non-physical resource (not cash or a receivable) that the business can point to specifically—so it is more than general reputation—and that is expected to help generate benefits in future periods.

Identifiable
A resource that is clearly specified and distinguishable, because it can be dealt with separately or because the entity has legally protected or contract-backed entitlement.

Control
The practical ability to access the benefits from the resource and prevent others from using it, typically via contracts, legal protection, or effective confidentiality.

Probable future economic benefits
Credible evidence that the resource is expected to contribute benefits such as revenue, licence/subscription income, or measurable cost savings.

Reliable measurement
The ability to measure and record expenditure using dependable records that track costs directly attributable to the asset or project.

Exploration (research) stage
Early investigation and evaluation work where outcomes are uncertain; costs are expensed as incurred.

Build (development) stage
Work directed toward building a usable/saleable output once completion, expected benefits, resourcing, and reliable cost tracking can be evidenced; qualifying directly attributable costs may be recognised as an intangible asset.

Cost model
Carrying amount equals cost less accumulated amortisation (if applicable) and accumulated impairment losses.

Revaluation model
Carrying amount based on fair value after revaluation, permitted only when an active market exists and values are kept up to date.

Amortisation
Systematic allocation of the cost of a finite-life intangible asset over its useful life, starting when the asset is available for use.

Indefinite useful life
No foreseeable limit to the period over which the asset is expected to generate benefits; the asset is not amortised and is tested for impairment at least annually.

Recoverable amount
A supportable estimate of what can be recovered from an asset (or CGU), based on the higher of discounted value from use and a net selling amount after disposal costs.

Cash-generating unit (CGU)
The smallest identifiable group of assets that generates cash inflows largely independent of cash inflows from other assets.

Impairment loss
The amount by which carrying amount exceeds recoverable amount, recognised in profit or loss and reducing the carrying amount of the asset (or allocated within the CGU).